Bharat Biotech signs agreements with US, Brazil to export, outsource COVAXIN production
The first interim reading of efficacy data from Phase III will be out in March, according to Bharat Biotech MD and CEO Dr Krishna Ella.
from http://www.firstpost.com/india/bharat-biotech-signs-agreements-with-us-brazil-to-export-outsource-covaxin-production-9268541.html
from http://www.firstpost.com/india/bharat-biotech-signs-agreements-with-us-brazil-to-export-outsource-covaxin-production-9268541.html
No comments: